New 'Tumor-Agnostic' drug trial targets dozens of advanced cancers

NCT ID NCT04482309

Recruiting now Disease control Sponsor: AstraZeneca Source: ClinicalTrials.gov ↗

Summary

This study is testing whether an existing cancer drug called T-DXd can help treat many different advanced cancers that have a specific protein marker called HER2. It will enroll about 468 adults with cancers like bladder, ovarian, pancreatic, and cervical cancer that have spread and have stopped responding to other treatments. The main goal is to see if the drug shrinks tumors and is safe for patients with these varied cancer types.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PART 1: BLADDER, BILIARY TRACT, CERVICAL, ENDOMETRIAL, OVARIAN, PANCREATIC CANCER, RARE TUMORS, ANY TUMOR TYPE EXCLUDING BREAST, GASTRIC, COLORECTAL CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Research Site
WITHDRAWN

Burbank, California, 91505, United States
Research Site
RECRUITING

Duarte, California, 91010, United States
Research Site
WITHDRAWN

Fullerton, California, 92835, United States
Research Site
WITHDRAWN

La Jolla, California, 92093, United States
Research Site
WITHDRAWN

Los Angeles, California, 90095, United States
Research Site
RECRUITING

Santa Rosa, California, 95403, United States
Research Site
RECRUITING

Chicago, Illinois, 60637, United States
Research Site
RECRUITING

Muncie, Indiana, 47303, United States
Research Site
RECRUITING

Boston, Massachusetts, 02215, United States
Research Site
WITHDRAWN

Detroit, Michigan, 48201, United States
Research Site
WITHDRAWN

St Louis, Missouri, 63110, United States
Research Site
RECRUITING

Middletown, New Jersey, 07748, United States
Research Site
RECRUITING

Harrison, New York, 10604, United States
Research Site
RECRUITING

New York, New York, 10029, United States
Research Site
RECRUITING

New York, New York, 10065, United States
Research Site
WITHDRAWN

Rochester, New York, 14642, United States
Research Site
COMPLETED

Durham, North Carolina, 27710, United States
Research Site
WITHDRAWN

Columbus, Ohio, 43210, United States
Research Site
WITHDRAWN

Nashville, Tennessee, 37203, United States
Research Site
RECRUITING

Houston, Texas, 77030, United States
Research Site
WITHDRAWN

Fairfax, Virginia, 22031, United States
Research Site
RECRUITING

Seattle, Washington, 98195, United States
Research Site
COMPLETED

Auchenflower, 4066, Australia
Research Site
RECRUITING

Blacktown, 2148, Australia
Research Site
COMPLETED

Camperdown, 2050, Australia
Research Site
COMPLETED

Heidelberg, 3084, Australia
Research Site
RECRUITING

Melbourne, 3000, Australia
Research Site
RECRUITING

Nedlands, 6009, Australia
Research Site
COMPLETED

Brussels, 1090, Belgium
Research Site
WITHDRAWN

Brussels, 1200, Belgium
Research Site
COMPLETED

Leuven, 3000, Belgium
Research Site
COMPLETED

Liège, 4000, Belgium
Research Site
WITHDRAWN

Barretos, 14784-400, Brazil
Research Site
WITHDRAWN

Curitiba, 81520-060, Brazil
Research Site
WITHDRAWN

Natal, 59075-740, Brazil
Research Site
SUSPENDED

Porto Alegre, 90035-000, Brazil
Research Site
WITHDRAWN

Porto Alegre, 90035-003, Brazil
Research Site
WITHDRAWN

Porto Alegre, 91350-200, Brazil
Research Site
WITHDRAWN

Ribeirão Preto, 14051-140, Brazil
Research Site
RECRUITING

São Paulo, 01246-000, Brazil
Research Site
RECRUITING

Vitória, 29043-272, Brazil
Research Site
RECRUITING

Kelowna, British Columbia, V1Y 5L3, Canada
Research Site
WITHDRAWN

Hamilton, Ontario, L8V 5C2, Canada
Research Site
WITHDRAWN

London, Ontario, N6A 5W9, Canada
Research Site
RECRUITING

Ottawa, Ontario, K1H 8L6, Canada
Research Site
WITHDRAWN

Montreal, Quebec, H2X 0A9, Canada
Research Site
RECRUITING

Québec, Quebec, G1J 1Z4, Canada
Research Site
RECRUITING

Montreal, H3T 1E2, Canada
Research Site
COMPLETED

Brno, 656 53, Czechia
Research Site
COMPLETED

Hradec Králové, 500 05, Czechia
Research Site
COMPLETED

Olomouc, 77900, Czechia
Research Site
WITHDRAWN

Ostrava, 708 52, Czechia
Research Site
COMPLETED

Prague, 150 06, Czechia
Research Site
COMPLETED

Prague, 180 81, Czechia
Research Site
COMPLETED

Delhi, 110085, India
Research Site
COMPLETED

Gūrgaon, 122001, India
Research Site
COMPLETED

Kolkata, 700160, India
Research Site
WITHDRAWN

Madurai, 625107, India
Research Site
COMPLETED

Mumbai, 400012, India
Research Site
WITHDRAWN

Mumbai, 400053, India
Research Site
WITHDRAWN

Nashik, 422002, India
Research Site
RECRUITING

Milan, 20141, Italy
Research Site
RECRUITING

Milan, 20162, Italy
Research Site
NOT_YET_RECRUITING

Naples, 80131, Italy
Research Site
WITHDRAWN

Roma, 00128, Italy
Research Site
RECRUITING

Rome, 168, Italy
Research Site
RECRUITING

Chūōku, 104-0045, Japan
Research Site
RECRUITING

Kashiwa, 277-8577, Japan
Research Site
RECRUITING

Suita-shi, 565-0871, Japan
Research Site
COMPLETED

Amsterdam, 1066CX, Netherlands
Research Site
COMPLETED

Delft, 2625 AD, Netherlands
Research Site
COMPLETED

Groningen, 9700, Netherlands
Research Site
RECRUITING

Bydgoszcz, 85-796, Poland
Research Site
RECRUITING

Gdansk, 80-952, Poland
Research Site
WITHDRAWN

Gliwice, 44-101, Poland
Research Site
RECRUITING

Krakow, 31-501, Poland
Research Site
COMPLETED

Poznan, 60-355, Poland
Research Site
RECRUITING

Warsaw, 02-781, Poland
Research Site
COMPLETED

Kaluga, 248007, Russia
Research Site
ACTIVE_NOT_RECRUITING

Moscow, 115419, Russia
Research Site
COMPLETED

Moscow, 115478, Russia
Research Site
COMPLETED

Moscow, 117997, Russia
Research Site
COMPLETED

Moscow, 121205, Russia
Research Site
ACTIVE_NOT_RECRUITING

Moscow, 143423, Russia
Research Site
COMPLETED

Moscow, 143442, Russia
Research Site
COMPLETED

Saint Petersburg, 195271, Russia
Research Site
COMPLETED

Saint Petersburg, 197758, Russia
Research Site
RECRUITING

Seoul, 03080, South Korea
Research Site
RECRUITING

Seoul, 03722, South Korea
Research Site
COMPLETED

Seoul, 06351, South Korea
Research Site
RECRUITING

Seoul, 5505, South Korea
Research Site
RECRUITING

Barcelona, 8035, Spain
Research Site
COMPLETED

Córdoba, 14004, Spain
Research Site
RECRUITING

Madrid, 28027, Spain
Research Site
COMPLETED

Madrid, 28040, Spain
Research Site
RECRUITING

Madrid, 28041, Spain
Research Site
RECRUITING

Madrid, 28046, Spain
Research Site
COMPLETED

Valencia, 46014, Spain
Research Site
RECRUITING

Taichung, 40705, Taiwan
Research Site
RECRUITING

Tainan, 736, Taiwan
Research Site
RECRUITING

Taipei, 100, Taiwan
Research Site
RECRUITING

Taipei, 10449, Taiwan
Research Site
RECRUITING

Taipei, 11217, Taiwan
Research Site
RECRUITING

Taoyuan District, 333, Taiwan
Research Site
RECRUITING

Bangkok, 10210, Thailand
Research Site
WITHDRAWN

Bangkok, 10300, Thailand
Research Site
RECRUITING

Bangkok, 10330, Thailand
Research Site
WITHDRAWN

Bangkok, 10330, Thailand
Research Site
TERMINATED

Bangkok, 10400, Thailand
Research Site
RECRUITING

Bangkok, 10400, Thailand
Research Site
WITHDRAWN

Bangkok, 10700, Thailand
Research Site
RECRUITING

Chiang Mai, 50200, Thailand
Research Site
RECRUITING

Hat Yai, 90110, Thailand
Research Site
RECRUITING

Khon Kaen, 40002, Thailand
Research Site
WITHDRAWN

Muang, 34000, Thailand
Research Site
RECRUITING

Muang, 50200, Thailand
Research Site
RECRUITING

Ongkharak, 26120, Thailand
Research Site
WITHDRAWN

Si Sa Ket, 33000, Thailand
Research Site
WITHDRAWN

Glasgow, G12 0YN, United Kingdom
Research Site
RECRUITING

London, SW2 6JJ, United Kingdom
Research Site
RECRUITING

Manchester, M20 4BX, United Kingdom
Research Site
WITHDRAWN

Northwood Middlesex, HA6 2RN, United Kingdom
Research Site
RECRUITING

Sutton, SM2 5PT, United Kingdom

Conditions

Explore the condition pages connected to this study.

PART 1: BLADDER, BILIARY TRACT, CERVICAL, ENDOMETRIAL, OVARIAN, PANCREATIC CANCER, RARE TUMORS, ANY TUMOR TYPE EXCLUDING BREAST, GASTRIC, COLORECTAL CANCER PART 2: HER2 EXPRESSING/AMPLIFIED SOLID TUMORS EXCLUDING BREAST, GASTRIC, COLORECTAL CANCER